Stay updated on Secured Access to Nivolumab for Rare Cancers Clinical Trial

Sign up to get notified when there's something new on the Secured Access to Nivolumab for Rare Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Secured Access to Nivolumab for Rare Cancers Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the nivolumab study is displayed, including its study design, eligibility criteria, outcomes, collaborators, and record dates, in place of the previous 403 error.
    Difference
    54%
    Check dated 2026-11-08T06:11:21.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.2 to v3.8.0; the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T04:23:56.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A site-wide notice announces NIH website updates and says that “Super Intelligence” may appear in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T06:34:04.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T06:33:28.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The site footer's revision label was updated from v3.7.0 to v3.7.1, while the study record continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T08:37:20.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    A new revision tag 'Revision: v3.7.0' was added to the page to indicate the current interface version; several metadata terms and related sections were removed from the study record view, altering what appears on the page.
    Difference
    19%
    Check dated 2026-09-20T04:27:26.000Z thumbnail image

Stay in the know with updates to Secured Access to Nivolumab for Rare Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Secured Access to Nivolumab for Rare Cancers Clinical Trial page.